Wakelee HA, Stephenson P, Keller SM , et al. Eastern Cooperative Oncology Group.
Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590.
Lung Cancer 2005;
48 (3) 389-397
Bibliographische Angaben herunterladen